ArticleAnnals of hematology2024

Comparison of tucidinostat with CHOP-like versus CHOP-like in first-line treatment of peripheral T-cell lymphoma: a single-center real-world study.

Xiaolian Wen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.